<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019d2b6c-fa32-7e7b-bcd4-65ba6d185b34,g:fe278b08-d792-4e53-8879-3ccd13d83add-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="https://xbrl.org/2023/arcrole/summation-item" xlink:type="simple" xlink:href="https://www.xbrl.org/2023/calculation-1.1.xsd#summation-item"/>
  <link:roleRef roleURI="http://vtvtherapeutics.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="vtvt-20260331.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://vtvtherapeutics.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_019d2b6c-faef-767f-b2b7-9b5bfbe0e0bb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_019d2b6c-faef-7485-a3c9-63010c2bddf5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_019d2b6c-faef-767f-b2b7-9b5bfbe0e0bb" xlink:to="loc_us-gaap_LiabilitiesCurrent_019d2b6c-faef-7485-a3c9-63010c2bddf5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtvt_WarrantyLiability_019d2b6c-faef-7f61-bed2-c359e528f62c" xlink:href="vtvt-20260331.xsd#vtvt_WarrantyLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_019d2b6c-faef-767f-b2b7-9b5bfbe0e0bb" xlink:to="loc_vtvt_WarrantyLiability_019d2b6c-faef-7f61-bed2-c359e528f62c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_019d2b6c-faef-7e0f-99b4-838299e9a6b3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_019d2b6c-faef-767f-b2b7-9b5bfbe0e0bb" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_019d2b6c-faef-7e0f-99b4-838299e9a6b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_019dbeae-d29c-7be2-97ba-9726e75e692b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_019dbeae-d29c-783c-8134-4f58c715dd10" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_019dbeae-d29c-7be2-97ba-9726e75e692b" xlink:to="loc_us-gaap_Liabilities_019dbeae-d29c-783c-8134-4f58c715dd10" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_019dbeae-d29c-76c2-b922-4dfb47f4a139" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_019dbeae-d29c-7be2-97ba-9726e75e692b" xlink:to="loc_us-gaap_CommitmentsAndContingencies_019dbeae-d29c-76c2-b922-4dfb47f4a139" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_019dbeae-d29c-7ad6-97b8-aa891ce802ff" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_019dbeae-d29c-7be2-97ba-9726e75e692b" xlink:to="loc_us-gaap_StockholdersEquity_019dbeae-d29c-7ad6-97b8-aa891ce802ff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_019d2b6c-faef-7d4b-a7cf-43aed1a2feba" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_019d2b6c-faef-7789-85c5-b26c5de1bd31" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_019d2b6c-faef-7d4b-a7cf-43aed1a2feba" xlink:to="loc_us-gaap_OtherAssetsCurrent_019d2b6c-faef-7789-85c5-b26c5de1bd31" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_019d2b6c-faef-7401-b956-777fc127ed6c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_019d2b6c-faef-7d4b-a7cf-43aed1a2feba" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_019d2b6c-faef-7401-b956-777fc127ed6c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019d2b6c-faef-7e7c-8fc6-84b285db8a8a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_019d2b6c-faef-7d4b-a7cf-43aed1a2feba" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019d2b6c-faef-7e7c-8fc6-84b285db8a8a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_019d2b6c-faef-7e72-a647-91fdef2bb556" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_019d2b6c-faef-7766-be1c-207407c3ba4e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019d2b6c-faef-7e72-a647-91fdef2bb556" xlink:to="loc_us-gaap_AssetsCurrent_019d2b6c-faef-7766-be1c-207407c3ba4e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_019d2b6c-faef-7de7-b0f3-4faeac267ea8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019d2b6c-faef-7e72-a647-91fdef2bb556" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_019d2b6c-faef-7de7-b0f3-4faeac267ea8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_019d2b6c-faef-731e-8e6c-4318a0f673f3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_019d2b6c-faef-76b3-8353-9b28952da538" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019d2b6c-faef-731e-8e6c-4318a0f673f3" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_019d2b6c-faef-76b3-8353-9b28952da538" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_019d2b6c-faef-7632-8f37-8733aa66d2c3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019d2b6c-faef-731e-8e6c-4318a0f673f3" xlink:to="loc_us-gaap_CommonStockValue_019d2b6c-faef-7632-8f37-8733aa66d2c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_019d2b6c-faef-78ab-b3de-91e2fcec59c3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019d2b6c-faef-731e-8e6c-4318a0f673f3" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_019d2b6c-faef-78ab-b3de-91e2fcec59c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_019d2b6c-faef-7714-ba58-b4ca9b11a343" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_019d2b6c-faef-7542-92d6-9572cf2b7675" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_019d2b6c-faef-7714-ba58-b4ca9b11a343" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_019d2b6c-faef-7542-92d6-9572cf2b7675" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtvt_WarrantLiabilityCurrent_019d68aa-70fa-7102-a730-dccd6a586f18" xlink:href="vtvt-20260331.xsd#vtvt_WarrantLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_019d2b6c-faef-7714-ba58-b4ca9b11a343" xlink:to="loc_vtvt_WarrantLiabilityCurrent_019d68aa-70fa-7102-a730-dccd6a586f18" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://vtvtherapeutics.com/role/CondensedConsolidatedStatementsofOperationsUnaudited" xlink:type="simple" xlink:href="vtvt-20260331.xsd#CondensedConsolidatedStatementsofOperationsUnaudited"/>
  <link:calculationLink xlink:role="http://vtvtherapeutics.com/role/CondensedConsolidatedStatementsofOperationsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019d2b6c-faef-7472-853a-3d4f085846bf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_019d2b6c-faef-7073-a709-68f597bcb2e5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019d2b6c-faef-7472-853a-3d4f085846bf" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_019d2b6c-faef-7073-a709-68f597bcb2e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_019d2b6c-faef-7155-ad6b-5ec4ed9d8527" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019d2b6c-faef-7472-853a-3d4f085846bf" xlink:to="loc_us-gaap_InvestmentIncomeInterest_019d2b6c-faef-7155-ad6b-5ec4ed9d8527" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_019d2b6c-faef-7feb-a117-e21991d0f459" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019d2b6c-faef-7472-853a-3d4f085846bf" xlink:to="loc_us-gaap_OperatingIncomeLoss_019d2b6c-faef-7feb-a117-e21991d0f459" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019d2b6c-faef-7522-aa0a-63d3bdb4f584" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_019d2b6c-faef-7783-9482-3be8c6b4468c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019d2b6c-faef-7522-aa0a-63d3bdb4f584" xlink:to="loc_us-gaap_ProfitLoss_019d2b6c-faef-7783-9482-3be8c6b4468c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_019d2b6c-faef-7d67-93bc-b3829f2b47d4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019d2b6c-faef-7522-aa0a-63d3bdb4f584" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_019d2b6c-faef-7d67-93bc-b3829f2b47d4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_019d2b6c-faef-7c4c-9f8f-c3b1945f4ec7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_019d2b6c-faef-7f0b-aca8-4b3ad4b4bddd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_019d2b6c-faef-7c4c-9f8f-c3b1945f4ec7" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_019d2b6c-faef-7f0b-aca8-4b3ad4b4bddd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_019d2b6c-faef-7f27-839d-54c5066c166e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_019d2b6c-faef-7c4c-9f8f-c3b1945f4ec7" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_019d2b6c-faef-7f27-839d-54c5066c166e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_019d2b6c-faef-711c-8ae6-5cbf82531f44" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019d2b6c-faef-7fe8-8c26-1f1ff2329add" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_019d2b6c-faef-711c-8ae6-5cbf82531f44" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_019d2b6c-faef-7fe8-8c26-1f1ff2329add" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_019d2b6c-faef-79d6-90e5-4e3b32937ac7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_019d2b6c-faef-711c-8ae6-5cbf82531f44" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_019d2b6c-faef-79d6-90e5-4e3b32937ac7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_019d2b6c-faef-7a5a-a7e6-e145072d23cd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019d2b6c-faef-7a73-a3e7-f88cf1cd991c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_019d2b6c-faef-7a5a-a7e6-e145072d23cd" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019d2b6c-faef-7a73-a3e7-f88cf1cd991c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_019d2b6c-faef-7550-a66c-77545af2d32f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_019d2b6c-faef-7a5a-a7e6-e145072d23cd" xlink:to="loc_us-gaap_OperatingExpenses_019d2b6c-faef-7550-a66c-77545af2d32f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://vtvtherapeutics.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" xlink:type="simple" xlink:href="vtvt-20260331.xsd#CondensedConsolidatedStatementsofCashFlowsUnaudited"/>
  <link:calculationLink xlink:role="http://vtvtherapeutics.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019db5e7-f501-7256-88cc-58e352828df6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_019db5e7-f501-7e62-855d-f68c5e80bbfe" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019db5e7-f501-7256-88cc-58e352828df6" xlink:to="loc_us-gaap_ProfitLoss_019db5e7-f501-7e62-855d-f68c5e80bbfe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_019db5e7-f501-71fc-82fb-52b8116626fa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Depreciation"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019db5e7-f501-7256-88cc-58e352828df6" xlink:to="loc_us-gaap_Depreciation_019db5e7-f501-71fc-82fb-52b8116626fa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_019db5e7-f501-7fcf-9c27-bcc21aeb1848" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019db5e7-f501-7256-88cc-58e352828df6" xlink:to="loc_us-gaap_ShareBasedCompensation_019db5e7-f501-7fcf-9c27-bcc21aeb1848" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_019db5e7-f501-77e4-804e-c92939ca2ab0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019db5e7-f501-7256-88cc-58e352828df6" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_019db5e7-f501-77e4-804e-c92939ca2ab0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_019db5e7-f501-737e-9d0f-a515345cf650" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019db5e7-f501-7256-88cc-58e352828df6" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_019db5e7-f501-737e-9d0f-a515345cf650" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets_019db5e7-f501-7844-bfe5-3fe9d65cc833" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019db5e7-f501-7256-88cc-58e352828df6" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets_019db5e7-f501-7844-bfe5-3fe9d65cc833" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_019db5e7-f501-7ca0-8620-8317225f153a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019db5e7-f501-7256-88cc-58e352828df6" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_019db5e7-f501-7ca0-8620-8317225f153a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_019db5e7-f501-721a-8ccd-dfeb64640e0a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019db5e7-f501-7256-88cc-58e352828df6" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_019db5e7-f501-721a-8ccd-dfeb64640e0a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_019db5e7-f501-769a-8d71-4bbed779d017" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019db5e7-f501-7256-88cc-58e352828df6" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_019db5e7-f501-769a-8d71-4bbed779d017" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_019dbe88-00aa-705c-8d50-e87ceee4da40" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019db5e7-f501-7256-88cc-58e352828df6" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_019dbe88-00aa-705c-8d50-e87ceee4da40" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019db5e9-7a3b-74b7-baaa-cc474df6c6fb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019db5e9-7a3b-7d23-bbb5-c52b47d3d4fe" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019db5e9-7a3b-74b7-baaa-cc474df6c6fb" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019db5e9-7a3b-7d23-bbb5-c52b47d3d4fe" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://vtvtherapeutics.com/role/SegmentInformationScheduleofSegmentReportingInformationbySegmentDetails" xlink:type="simple" xlink:href="vtvt-20260331.xsd#SegmentInformationScheduleofSegmentReportingInformationbySegmentDetails"/>
  <link:calculationLink xlink:role="http://vtvtherapeutics.com/role/SegmentInformationScheduleofSegmentReportingInformationbySegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_019d2b6c-fb9b-7cce-b5d0-34675790bd71" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtvt_DirectResearchAndDevelopmentExpense_019d2b6c-fb9b-7cee-976f-f89efa28a683" xlink:href="vtvt-20260331.xsd#vtvt_DirectResearchAndDevelopmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense_019d2b6c-fb9b-7cce-b5d0-34675790bd71" xlink:to="loc_vtvt_DirectResearchAndDevelopmentExpense_019d2b6c-fb9b-7cee-976f-f89efa28a683" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vtvt_IndirectResearchDevelopmentExpense_019d2b6c-fb9b-7f27-8493-61d21f74ac77" xlink:href="vtvt-20260331.xsd#vtvt_IndirectResearchDevelopmentExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense_019d2b6c-fb9b-7cce-b5d0-34675790bd71" xlink:to="loc_vtvt_IndirectResearchDevelopmentExpense_019d2b6c-fb9b-7f27-8493-61d21f74ac77" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://vtvtherapeutics.com/role/NetIncomeLossperShareScheduleofReconciliationoftheNumeratorandDenominatorUsedintheCalculationofBasicandDilutedNetIncomeLossperShareofClassACommonStockDetails" xlink:type="simple" xlink:href="vtvt-20260331.xsd#NetIncomeLossperShareScheduleofReconciliationoftheNumeratorandDenominatorUsedintheCalculationofBasicandDilutedNetIncomeLossperShareofClassACommonStockDetails"/>
  <link:calculationLink xlink:role="http://vtvtherapeutics.com/role/NetIncomeLossperShareScheduleofReconciliationoftheNumeratorandDenominatorUsedintheCalculationofBasicandDilutedNetIncomeLossperShareofClassACommonStockDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_019d2b6c-fb9b-7de5-a413-1ea2b5a6615d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_019d2b6c-fb9b-7154-a1f1-cb6b3f7bc105" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_019d2b6c-fb9b-7de5-a413-1ea2b5a6615d" xlink:to="loc_us-gaap_ProfitLoss_019d2b6c-fb9b-7154-a1f1-cb6b3f7bc105" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_019d2b6c-fb9b-70fa-9156-a7328ff2815f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_019d2b6c-fb9b-7de5-a413-1ea2b5a6615d" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_019d2b6c-fb9b-70fa-9156-a7328ff2815f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_019d2b6c-fb9b-721b-bf2b-38955fe1224e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_019d2b6c-fb9b-7d03-9ea7-0ccdd0e48d95" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_019d2b6c-fb9b-721b-bf2b-38955fe1224e" xlink:to="loc_us-gaap_ProfitLoss_019d2b6c-fb9b-7d03-9ea7-0ccdd0e48d95" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_019d2b6c-fb9b-7c65-924d-c812a4e16157" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_019d2b6c-fb9b-721b-bf2b-38955fe1224e" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_019d2b6c-fb9b-7c65-924d-c812a4e16157" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
